What is PGT-A?
Preimplantation Genetic Testing for Aneuploidy (PGT-A) is a screening test used during IVF to check embryos for an abnormal number of chromosomes. It helps embryologists select embryos that are more likely to implant and develop normally. However, PGT-A is not a guarantee of a healthy pregnancy or baby, and it has important limitations that you should understand before deciding whether to use it.
At a Glance: Key Limitations of PGT-A
- PGT-A cannot detect all genetic disorders, only chromosomal number abnormalities.
- It cannot identify structural chromosome rearrangements (that’s PGT-SR).
- It cannot detect single-gene disorders (that’s PGT-M).
- Mosaicism results may be uncertain and require confirmatory testing.
- PGT-A does not eliminate the risk of miscarriage or birth defects.
- It cannot predict the health of a future child.
What PGT-A Can Detect
PGT-A screens for aneuploidy, which means having too many or too few chromosomes. This is a common cause of implantation failure and miscarriage. By identifying embryos with the correct number of chromosomes (euploid), PGT-A can help reduce the risk of miscarriage and improve the chances of a successful pregnancy in certain situations.
What PGT-A Cannot Detect
Single-Gene Disorders
PGT-A does not test for specific genetic diseases like cystic fibrosis, sickle cell anemia, or Huntington’s disease. For those, you would need PGT-M (Preimplantation Genetic Testing for Monogenic disorders), which is a different test that looks for specific gene mutations.
Structural Chromosome Abnormalities
PGT-A does not detect balanced translocations or other structural rearrangements of chromosomes. If you or your partner have a known chromosomal rearrangement, PGT-SR (Preimplantation Genetic Testing for Structural Rearrangements) is the appropriate test.
Mosaicism
Mosaicism occurs when an embryo has both normal and abnormal cells. PGT-A may report an embryo as mosaic, meaning it has a mix of cells with different chromosome numbers. The clinical significance of mosaicism is not fully understood, and the accuracy of the result depends on the biopsy sample. A mosaic embryo may still lead to a healthy baby, but it carries a higher risk of abnormalities. Confirmatory testing, such as prenatal diagnosis (amniocentesis or CVS), is often recommended if a mosaic embryo is transferred.
Epigenetic and Multifactorial Conditions
PGT-A does not assess epigenetic changes (how genes are expressed) or complex conditions like autism, diabetes, or heart disease, which are influenced by multiple genes and environmental factors.
Why PGT-A Results Are Not Absolute
PGT-A is a screening test, not a diagnostic test. It provides information about the chromosomes in the cells biopsied from the embryo, but it cannot guarantee that the embryo is completely normal. The biopsy samples only a few cells from the trophectoderm (the part that becomes the placenta), which may not represent the entire embryo. Additionally, technical limitations can lead to false positives or false negatives.
The Need for Confirmatory Testing
If you become pregnant after transferring a PGT-A tested embryo, your doctor may recommend prenatal testing, such as chorionic villus sampling (CVS) or amniocentesis, to confirm the chromosomal status of the fetus. This is especially important if the embryo was mosaic or if you have other risk factors.
Questions to Ask Your Clinic
- What type of genetic testing does your lab use for PGT-A?
- How does your clinic report mosaicism, and what is your policy on transferring mosaic embryos?
- What is the accuracy rate of PGT-A at your lab?
- Do you recommend confirmatory testing after a PGT-A pregnancy?
- What are the costs and timelines for PGT-A?
Next Steps: Making an Informed Decision
Before deciding on PGT-A, discuss with your fertility specialist:
- Your medical history and reasons for considering PGT-A.
- The limitations and potential benefits in your specific situation.
- Alternative options, such as not testing or using other screening methods.
- The emotional and financial implications.
Remember, PGT-A is a tool to help you make informed choices, but it is not a guarantee. Take your time, ask questions, and consider genetic counseling if needed.
For more information, explore our PGT in Thailand guide, visit our guides, or check our FAQ section.
Frequently asked questions
Can PGT-A detect all genetic abnormalities?
No, PGT-A only screens for an abnormal number of chromosomes (aneuploidy). It does not detect single-gene disorders, structural rearrangements, or complex conditions influenced by multiple genes and environment.
What is mosaicism in PGT-A results?
Mosaicism means an embryo has a mix of normal and abnormal cells. PGT-A may report an embryo as mosaic, but the clinical significance is uncertain. Confirmatory testing is often recommended if a mosaic embryo is transferred.
Is PGT-A a guarantee of a healthy baby?
No, PGT-A is a screening test that reduces the risk of miscarriage and chromosomal abnormalities, but it cannot guarantee a healthy pregnancy or baby. It does not detect all genetic conditions or birth defects.
Do I need confirmatory testing after PGT-A?
Your doctor may recommend prenatal testing, such as CVS or amniocentesis, to confirm the chromosomal status of the fetus, especially if the embryo was mosaic or you have other risk factors.
What is the difference between PGT-A and PGT-M?
PGT-A screens for an abnormal number of chromosomes, while PGT-M tests for specific single-gene disorders. They are used for different purposes and can be done together if needed.
Continue your research
Medical information notice: This article is educational and does not replace individual assessment, diagnosis, genetic counselling or treatment advice from a licensed clinician. Provider services, availability, fees and policies should be verified directly before booking.